Real-life data on the current use of eslicarbazepine acetate in Germany

M Holtkamp, D Lendemans, E Kockelmann - Zeitschrift für Epileptologie, 2016 - Springer
Background The anticonvulsant eslicarbazepine acetate (ESL) is licensed as adjunctive
therapy for adults with partial-onset seizures (POS). Objectives To gather information on the …

[PDF][PDF] ЗАКЛЮЧЕНИЕ

ГН Авакян - Epilepsy and paroxysmal conditions, 2016 - epilepsia.su
Ýпилепсия–одно из наиболее распространен-ных заболеваний в мире, которым
страдают дети и подростки, взрослые и пожилые; мужчины и женщины. В Российской …

[PDF][PDF] Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action

LC Wright - 2015 - academia.edu
Eslicarbazepine acetate (ESL) is a once daily antiepileptic drug (AED) approved by the
European Medicines Agency (EMA), the Food and Drug Administration (FDA) and Health …

[PDF][PDF] Carbamazepine and its Derivatives: What's the Difference?

R Citraro, S Chimirri, R Aiello, P Longo… - … AND ADVERSE EFFECTS - researchgate.net
Carbamazepine (CBZ) is one of the most used antiepileptic drugs (AEDs) worldwide. It was
introduced into the market in the early sixties and thereafter has become the most frequently …

Influência do verapamil na farmacocinética e na perfusão cerebral da oxcarbazepina e dos enantiômeros do metabólito 10-hidroxicarbazepina em voluntários sadios

NJ Antunes - 2014 - teses.usp.br
A oxcarbazepina (OXC) é indicada como terapia adjuvante ou monoterapia no tratamento
de crises epilépticas parciais ou crises tônico-clônicas generalizadas em adultos e crianças …

[引用][C] Antiepileptic Drugs (AED): New Drugs & New Uses

VA Boise